Medical research & trials · US
Medical research & trials · US · 14 stories in 48h · Clear all filters
- Nasdaq.com Edesa Biotech, Inc. Announces EU Orphan Designation for ParidiprubartOn November 17, 2026, Edesa Biotech, Inc. (the “Company”) announced that the European Commission has granted orphan designation…
- Nasdaq.com Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal CancerAdagene Inc. and City of Hope have announced the launch of an investigator-initiated Phase 1 clinical trial to…
-
Kernal Bio secures funding from IFLI for lymphoma treatment
-
Valion Bio completes 200-liter Entolimod production run
-
Reuters
J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion
2 sources · Reuters, Investing.com
-
Protagonist Therapeutics at Jefferies Global Healthcare Conference: partner-led growth
-
‘Orwellian’: HIV scientist’s ordeal lays bare Trump officials’ interference in grant-makingResearchers forced to scrap original studies as NIH rethinks grants not in ‘alignment’ with administration’s priorities Dr Jade…
-
Common blood pressure drug helps more stroke survivors reach critical health targetThe REDUCE trial found spironolactone lowered blood pressure by nearly eight points in stroke survivors, but key questions…
- Investing.com EyePoint at UBS biopharma conference: DME hopes offset wet AMD setback
-
NKGen presents Alzheimer’s patient data at CTAD conference
-
Corvus Pharmaceuticals at Jefferies conference: oral ITK drug gains ground
-
IN8bio reports survival data from glioblastoma trial
-
United Therapeutics at UBS Global Biopharma Conference 2026: 2027 catalyst year
-
Ionis at UBS Global Biopharma Conference 2026: launch pace in focus
2 more stories in other languages (Portuguese 1, Spanish 1) ·